Articles related to Anesthesiology

Gain insights into the new, evidence-based guidelines for managing postdural puncture headache, a condition that has long been in need of standardized care protocols.

The evolving use of dopamine D2-receptor antagonists, marked by safety concerns and an FDA black box warning on droperidol, has seen a resurgence with the FDA-approved amisulpride, highlighting the need for further research to explore its comparison with other antiemetics and its role in multimodal PONV management.

FDA Cautions Against Hidden Drug Ingredients in Joint Pain Supplements In response to recent findings, the FDA warns of significant health risks associated with three specific dietary supplements marketed for joint pain and rheumatoid arthritis relief due to the discovery of unlisted active pharmaceutical ingredients.

Dive into the essence of AANA’s updated guidelines for obstetric anesthesia and analgesia as we spotlight its focus on health equity and safety in maternal care. Commencing with the unveiling of the revised practice guidelines for obstetric anesthesia and analgesia, the American Association of Nurse Anesthesiology (AANA) has emphasized enhancing patient care and safety. Interestingly, these updates also strive to tackle the critical issue of enduring health disparities in the United States. The AANA firmly believes in the power of certified registered nurse anesthetists (CRNAs) to help curb maternal mortality rates. The primary strategy focuses on mitigating racial and ethnic imbalances in pregnancy-related deaths. Beth Ann Clayton, DNP, CRNA, FAANA, FAAN, the key subject matter expert behind the revisions, underscores these inequalities as significant barriers to optimal maternal care. Using an evidence-based process, the AANA revised the guidelines, paying careful attention to current research. They’ve prioritized enhancing the readability of the content, updating the quality of references, and broadening their scope to encompass the most recent recommendations on obstetric analgesia and anesthesia care. The notable alterations include the broadening of analgesia and anesthesia considerations for labor and delivery. This expansion encompasses inhalation analgesia, neuraxial analgesia, general anesthesia, and an updated […]

Northwestern University Feinberg School of Medicine has once again been recognized as one of the top medical schools in the nation, ranking 13th among research-oriented institutions, according to the latest US News & World Report rankings. This marks the 16th consecutive year that Feinberg has placed in the top 20. The rankings underwent changes in methodology, incorporating factors such as federal research awards, surveys completed by deans and senior faculty at peer institutions, and entering class data. Feinberg’s commitment to patient-centered care, breakthrough discoveries, innovation, and exceptional medical education remains unwavering. Feinberg’s specialty programs also received recognition, with seven programs ranking among the best in the nation, including obstetrics and gynecology, surgery, pediatrics, anesthesiology, radiology, psychiatry, and internal medicine. The physician assistant program saw a notable improvement in its ranking, moving from 26th to 8th. Additionally, Feinberg’s school of public health ranked 28th. With its rich history, cutting-edge scientific initiatives, and outstanding faculty, Feinberg continues to be a leading institution within Northwestern Medicine, dedicated to advancing healthcare and improving patient outcomes.

Nearly 25% of fentanyl powder seized in 48 states in 2022 contained xylazine. Xylazine causes severe injection site wounds that can require amputation and puts drug users at higher risk for overdose and death.